Small Animal Imaging (In-vivo) Market Size, Share & Trends Analysis Report By Technology (Optical Imaging, Micro-Magnetic Resonance Imaging, Nuclear Imaging), By Application, And Segment Forecasts, 2012 - 2022

Published: May, 2018 | Pages: 110 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global small animal imaging (In-Vivo) market size is expected to reach 2.7 billion by 2022, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.0% during the forecast period. Rising number of medical conditions requiring precise research for development of treatment options is anticipated to stoke the demand for small animal imaging over the forecast period.

Importance of these devices in applications such as defining mechanism of action, drug receptor targeting, and epigenetic research studies are projected to provide substantial growth for the market. Some of the major drivers of small animal imaging (in-vivo) market are technical innovations such as high-resolution MRI with other modalities, growing number of research and pharmaceutical organizations, increasing investments of CROs in pre-clinical studies, and rising adoption of multi-functional pre-clinical imaging.

Further key findings from the report suggest:

• Optical imaging was the largest segment in 2014 owing to rapid and easy operations and relatively cost-effective in comparison to other devices

• Micro-MRI technology is anticipated to be the fastest growing segment over the forecast period due varied applications during anatomical and functional analysis in developing mouse embryos and neonates

• In 2014, bio-distribution and monitoring the treatment response dominated the market in terms of revenue

• The cancer cell detection segment is expected to show substantial growth due to the increasing prevalence of cancer and rising government initiatives for cancer diagnostics research

• North America was the largest region in terms of revenue in 2016. Vast pre-clinical research, increasing demand for rapid and advanced methods, established healthcare infrastructure, and favorable platform for R&D pertaining to technological advancements are the key factors driving the regional market

• Europe was the second largest region in 2014, due to a large number of clinical research and pharmaceutical organizations and diagnostic device manufacturers

• Asia Pacific is projected to be the fastest growing region over the forecast period owing to increasing clinical research activities, rising base of target population, and emerging economies

• Some of the key players are Promega Corporation, Inc.; Miltenyi Biotec GmbH; Life Technologies Corporation; FujiFilm Holding Corporation; Siemens AG; Thermo Fisher Scientific; Bruker Corporation; PerkinElmer Inc.; and Aspect Imaging Ltd.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources

Chapter 2. Executive Summary
2.1. Small Animal Testing (In-Vivo) market - Industry Summary and Key Buying Criteria, 2012 - 2022

Chapter 3. Small Animal Testing (In-Vivo) Industry Outlook
3.1. Small Animal Testing (In-Vivo) market segmentation
3.2. Small Animal Testing (In-Vivo) market size and growth prospects, 2012-2022
3.3. Small Animal Testing (In-Vivo) market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry analysis - Porter's
3.6. Small Animal Testing (In-Vivo) market PESTEL analysis, 2014

Chapter 4. Small Animal Imaging (In-Vivo) Technology Outlook
4.1. Small Animal Imaging (In-Vivo) Market Share By Technology, 2014 & 2022
4.2. Micro-magnetic resonance imaging
4.2.1. Micro-magnetic resonance imaging market Estimates and Forecasts, 2012 - 2022
4.3. Optical imaging
4.3.1. Optical imaging market Estimates and Forecasts, 2012 - 2022
4.4. Nuclear imaging
4.4.1. Nuclear imaging market Estimates and Forecasts, 2012 - 2022
4.5. Other imaging modalities
4.5.1. Other imaging modalities market Estimates and Forecasts, 2012 - 2022

Chapter 5. Small Animal Imaging (In-Vivo) Application Outlook
5.1. Small Animal Imaging (In-Vivo) Market Share By Application, 2014 & 2022
5.2. Monitoring treatment response
5.2.1. Cardiovascular disorders market Estimates and Forecasts, 2012 - 2022
5.3. Bio-distribution, determining drug/target engagement
5.3.1. Autoimmune disorders Market Estimates and Forecasts, 2012 - 2022
5.4. Cancer cell detection
5.4.1. Neurology Market Estimates and Forecasts, 2012 - 2022
5.5. Biomarkers
5.5.1. Oncology Market Estimates and Forecasts, 2012 - 2022
5.6. Longitudinal studies
5.6.1. Others Market Estimates and Forecasts, 2012 - 2022
5.7. Epigenetics
5.7.1. Epigenetics Market Estimates and Forecasts, 2012 - 2022

Chapter 6. Small Animal Imaging (In-Vivo) Regional Outlook
6.1. Small Animal Imaging (In-Vivo) Market Share By Region, 2014 & 2022
6.2. North America
6.2.1. Market Estimates and Forecasts, by Technology, 2012 - 2022 (USD Million)
6.2.2. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
6.3. Europe
6.3.1. Market Estimates and Forecasts, by Technology, 2012 - 2022 (USD Million)
6.3.2. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
6.4. Asia Pacific
6.4.1. Market Estimates and Forecasts, by Technology, 2012 - 2022 (USD Million)
6.4.2. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
6.5. RoW
6.5.1. Market Estimates and Forecasts, by Technology, 2012 - 2022 (USD Million)
6.5.2. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)

Chapter 7. Competitive Landscape
7.1. Thermo Fisher Scientific
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Siemens AG
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Life Technologies Corporation
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Bruker Corporation
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. PerkinElmer, Inc
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Aspect Imaging Ltd.
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Promega Corporation
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives

List of Tables

1. Small animal imaging (in-vivo)- Industry Snapshot & Key Buying Criteria, 2012 - 2022
2. Small animal imaging (in-vivo) market, by technology, 2012 - 2022 (USD Million) 
3. Small animal imaging (In-Vivo) market, by application, 2012 - 2022 (USD Million) 
4. Small animal imaging (In-Vivo) market, by region, 2012 - 2022 (USD Million) 
5. North America small animal imaging (In-Vivo) market, by technology, 2012 - 2022 (USD Million)
6. North America small animal imaging (In-Vivo) market, by application, 2012 - 2022 (USD Million)
7. Europe small animal imaging (In-Vivo) market, by technology, 2012 - 2022 (USD Million) 
8. Europe small animal imaging (In-Vivo) market, by application, 2012 - 2022 (USD Million) 
9. Asia Pacific small animal imaging (In-Vivo) market, by technology, 2012 - 2022 (USD Million) 
10. Asia Pacific small animal imaging (In-Vivo) market, by application, 2012 - 2022 (USD Million) 
11. RoW small animal imaging (In-Vivo) market, by technology, 2012 - 2022 (USD Million)
12. RoW small animal imaging (In-Vivo) market, by application, 2012 - 2022 (USD Million)

List of Figures

1. Small animal imaging (In-Vivo) market share, by technology, 2014 & 2022 
2. Micro-Magnetic Resonance Imaging market, 2012 - 2022 (USD Million) 
3. Optical imaging market, 2012 - 2022 (USD Million) 
4. Nuclear imaging market, 2012 - 2022 (USD Million) 
5. Other Imaging modalities market, 2012 - 2022 (USD Million) 
6. Small animal imaging (In-vivo) market share, by application, 2014 & 2022 30
7. Monitoring treatment response market, 2012 - 2022 (USD Million) 
8. Bio distribution, determining drug/target engagement market, 2012 - 2022 (USD Million) 
9. Cancer cell detection market, 2012 - 2022 (USD Million)
10. Biomarkers market, 2012 - 2022 (USD Million) 
11. Longitudinal studies market, 2012 - 2022 (USD Million) 
12. Epigenetics market, 2012 - 2022 (USD Million) 
13. Small animal imaging (In-Vivo) revenue share by region, 2014 & 2022 
14. North America Small animal imaging (In-Vivo) Market, 2012 - 2022 (USD Million) 
15. Europe small animal imaging (In-Vivo) Market, 2012 - 2022 (USD Million) 
16. Asia Pacific small animal imaging (In-Vivo) Market, 2012 - 2022 (USD Million) 
17. RoW small animal imaging (In-Vivo) Market, 2012 - 2022 (USD Million)